JimJimJimJim Posted April 28, 2014 Share Posted April 28, 2014 Jim Marshall (not a doctor) said ... The ENZARAD trial is one of the two clinical trials of the drug Enzalutamide that have now begun in Australia. The ENZARAD trial is essentially for those who have high-risk prostate cancer but have had almost no treatment yet. Men in the trial will have standard radiation (external beam radiotherapy). Half the men will follow this by standard hormone therapy. The other half will use enzalutamide as their hormone therapy. You cannot enter this trial if you have had your prostate cancer treated by: surgery; radiation; or hormone treatment longer than 30 days. You have to be at high risk to enter the trial. Your biopsy score (Gleason score) must be: 8, 9 or 10; OR 7 (4+3) together with a PSA of 20 or more, OR 7(4+3), cancer in both sides of the prostate and a PSA of 10 or more. There are more detailed rules of how you may or may not qualify available from the trial site: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=365611 The hospitals offering this trial are: Westmead Hospital - Westmead Prince of Wales Private Hospital - Randwick Wollongong Hospital - Wollongong Calvary Mater Newcastle - Waratah Peter MacCallum Cancer Institute - East Melbourne Box Hill Hospital - Box Hill Austin Health - Austin Hospital - Heidelberg Royal Brisbane & Womens Hospital - Herston Princess Alexandra Hospital - Woolloongabba Mater Adult Hospital - South Brisbane Nambour General Hospital - Nambour Flinders Medical Centre - Bedford Park Repatriation Hospital - Daw Park Royal Perth Hospital - Perth Fremantle Hospital and Health Service - Fremantle Royal Hobart Hospital - Hobart PCFA also has an excellent description of this trial at: http://www.prostate.org.au/articleLive/pages/Australian-Organisation-Launches-Large-International-Clinical-Trials-in-Prostate-Cancer.html ... end Jim Link to comment Share on other sites More sharing options...
This topic is now archived and is closed to further replies.